Biotech Research Associate

Research Associate – Biotech Equity Research Join a Top-Ranked Research Platform Where Your Impact Matters from Day One

For more than 25 years,

B. Riley Securities has built its reputation as a premier small- and mid-cap research boutique recognized across the Street for exceptional stock-picking performance. With approximately 400 companies under coverage and a fundamentals-driven approach, our platform generates alpha-producing ideas that institutional investors trust. We are seeking a Biotech Research Associate to join our Healthcare Equity Research team and our proven analyst development track.

• Clear path to analyst. We promote from within—our track record speaks for itself.
• Rapid responsibility. Small teams mean direct exposure to senior leadership and meaningful ownership from day one.
• Mentorship that matters. Mentor-led groups and monthly stock pitch competitions, with bonus compensation for winners and consistent excellence required for promotion.
• C-suite and KOL access. Management meetings, medical conferences, analyst days, and BRS-led investor events.
• Published research. Co-author notes and coverage initiations once licensed.

The Biotech Research Associate supports senior analyst coverage across oncology/hematology, immunology/inflammation, cardio-metabolism, CNS/neurology, and ophthalmology, contributing directly to published research on both commercial and development-stage companies in a fast-paced, catalyst-driven environment. Success looks like rapidly developing ownership of models and therapeutic area databases, producing clean first drafts under deadline, and building toward independent company coverage.

• Support biotech and pharmaceutical public equity coverage, including earnings, clinical data readouts, and medical conference events (e.g., AACR, ADA, ASCO, ASH, ESMO, AAN, EHA, Obesity Week, WCLC).
• Conduct scientific, clinical, regulatory, and competitive due diligence, distilling what matters for the investment thesis.
• Track catalysts across the coverage universe and communicate developments to the team on a timely basis.

Modeling & Data

• Build and maintain financial models, including revenue builds, probability-adjusted forecasts, and comp sheets.
• Develop and maintain therapeutic class, disease area, and regulatory precedent databases.
• Construct forecasts and sensitivity analyses that support investment recommendations.
• Draft research notes, flash updates, and companion sales materials requiring minimal editing before publication.
• Communicate actionable ideas on morning/midday calls and respond to requests from the sales force and institutional clients.
• Participate in management calls, KOL discussions, investor conferences, and corporate access initiatives.

Foundational Excellence

• Obtain all FINRA licenses (SIE, Series 7, 63, 86/87) within the first six months.
• Master financial modeling, accounting fundamentals, and the therapeutic areas under coverage.
• Demonstrate a "can do" attitude and independent resourcefulness.

Senior Associate Progression

• Develop proprietary insight into coverage names and proactively identify timely product ideas.
• Handle client requests independently when the analyst is unavailable.
• Build complex models with accurate forecasting.

Analyst Readiness

• Manage several names under coverage with minimal supervision.
• Develop and maintain corporate and KOL relationships that secure valuable access.
• Lead new coverage launches from initiation through publication.

Required

• One to three years of experience in biotechnology/pharmaceuticals via equity research, investment banking, consulting, industry, or clinical/scientific roles; OR an advanced scientific degree with demonstrated interest in public markets.
• Ability to interpret clinical and scientific data and translate findings into investment implications.
• Solid financial modeling and analytical skills with advanced Excel proficiency.
• Strong written communication and attention to detail under deadline pressure.
• Willingness to obtain required FINRA licenses (SIE, Series 7, 63, 86/87) post-hire; existing licences a plus.
• Strong…